Chen Y, Kuchroo VK, Inobe J-I et ,il (1994) Regulatory T cell cloncs induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
Chen Y, Inobe J-I, Marks R et al (1995) Peripheral deletion of antigen-rcactive T cells in oral tolerance. Nature 376: 177-180.
Chen Y, Inobe J-i, Kuchroo VK et al (1996) Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proceedings of the National Academy of Sciences of the USA 93: 388-391.
Daniel D and Wegmann DR (1996) Protection of non-obese diabetic mice from diabetics by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proceedings of the National Academy of Sciences of the USA 93: 956-960. Friedman A and Weiner HI. (1994) Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proceedings of the National Academy of Sciences of the USA 91: 6688-6692. Fukaura H, Kent SC, Pietrusewicz MJ et al (1996) Induction of circulating myelin basic protein and proteolipid protein specific TGF-f51 secreting T cells by oral administration of myelin in multiple sclerosis patients. Journal of Clinical Investigation 98: 70-77. Husby S, Mestecky J, Moldoveanu Z et al (1994) Oral tolerance in humans: Tcell but not B cell tolerance after antigen feeding. Journal of immunology 152: 4663-4670.
Metzlcr B and Wraith DC (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. International Immunology 5: 1159-1165. Miller A, Lider O and Weiner HI. (1991) Antigen-driven bystander suppression following oral administration of antigens. Journal of Experimental Medicine 174: 791-798.
Neurath MF, Fuss I, Kelsall BI. et al (1996) F.xperimental granulomatous colitis in mice is abrogated by induction of TGF-3-mediated oral tolerance. Journal of Experimental Medicine 183: 2605-2616. Nussenblatt RB, Caspi RR, Mahdi R et al (1990) Irihi-
bition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-anti-gen. Journal of immunology 144: 1689-1695.
Sun J-B, Holmgren C and Czerkinsky C (1994) Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proceedings of the National Academy of Sciences of the USA 91: 10795-10799.
Tian J, Atkinson MA, Clare-Salzler M et al (1996) Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. Journal of Experimental Medicine 183: 1561-1567.
Trentham DE, Dynesius-Trentham RA, Orav EJ et al (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261: 1727-1730.
Weiner HL (1997) Oral tolerance: immune mcchanisms and treatment of autoimmune diseases. Immunology Today 18: 335-343.
Weiner HI. (1997) Oral tolerance for the treatment of autoimmune diseases. Annual Review of Medicine 48: 341-351.
Weiner HI. and Mayer LF (eds) (1996) Oral Tolerance: Mechanisms and Applications. New York: New York Academy of Sciences.
Weiner HL, Mackin GA, Matsui M et al (1993) Doubleblind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
Whitacre CC, Gicnapp IE, Orosz CG and Bitar D ( 1 991 ) Oral tolerancc in experimental autoimmune encephalo-myelits. III. Evidence for clonal anergy. journal of Immunology 147: 2155-2163.
Zhang JA, Davidson L, Eisenbarth G and Weiner HI. (1991) Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proceedings of the National Academy of Sciences of the USA 88: 10252-10256.
Was this article helpful?
Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.